SLC2A1 and non-small cell lung carcinoma: The genes used for evaluation were defined according to a number of microarray-based studies (three genes: AGFG1/HRB, STC1, SLC2A1 that overlap between NSCLC prognostic signatures), comprehensive real-time PCR analyses, and/or protein-evaluating assays [6–17].